MLN4924 (MLN-4924)
英文名称: MLN4924 (MLN-4924)
型号:null    产品货号: IUP1051-0200UG
价格:请致电:010-57128832,18610462672
品牌: gene operation

 IUP1051-MLN4924

MLN4924 (MLN-4924), >98%

【英文同义名】:MLN-4924, MLN 492

【中文同义名】:

订购信息:(原装进口,常备现货)

 

产品名称

产品货号

目录价(元)

Gene Operation

MLN4924

 (NEDD8-activating enzyme inhibitor)

IUP1051-0200UG

200UG

1629.00

IUP1051-0001MG

1MG

3369.00

IUP1051-0005MG

5MG

5429.00

产品描述

MLN4924(同义名: MLN-4924, MLN 4924) 是一种强效的NEDD8活化酶(NAE) 选择性抑制剂,IC50=4.7 nM,能抑制cullin-RING E3泛素连接酶,稳定多数cullin底物(如Cdt1, p27 NRF2),诱导NDA再次复制,并伴随有DNA损伤和细胞死亡[1]MLN4924具有广泛的抗肿瘤活性,抑制多数人肿瘤细胞生长,包括实体瘤(结肠,肺)和恶性血液肿瘤(骨髓瘤,淋巴瘤)[2]MLN4924在体内外还可以抑制NF-κB通路,从而诱导细胞凋亡和肿瘤衰退[3]。另外,在体外胰腺癌细胞和体内胰腺癌移植瘤小鼠模型中,MLN4924还表现出明显的辐射增敏作用[4]。目前正用于I期临床实验。

靶点

靶点

NAE

IC50(半数有效浓度)

4.7 nM

化学特性

Cas No.: 905579-51-3

分子量: 443.52

分子式: C21H25N5O4S

纯度: >98% 

同义名: MLN-4924, MLN 4924

化学名: ((1S,2S,4R)-4-(4-(((S)-2,3-dihydro-1H-inden-1-yl)amino)-7H-pyrrolo [2,3 -d]pyrimidin-7-yl)-2-hydroxycyclopentyl)methyl sulfamate

外观: 白色粉末

溶解: 溶于DMSO(up to 10 mg/mL)

保存:3 -20 粉末

储存液配制

储存液 (1 ml DMSO体系)

1 mM

5 mM

10 mM

质量(mg)

0.3842

1.9212

3.8424

结构式

使用浓度(仅作参考)

MLN4924的具体使用浓度请参考相关文献,并根据自身实验条件(如实验目的,细胞种类,培养特性等)进行摸索和优化。

参考文献

[1] Soucy, TA, et al. An inhibitor of NEDD8-activating enzyme as a new approach to treat cancer. Nature. 458(7239): 732-6 (2009). 

[2] Lin, J.J., et al. NEDD8-Targeting Drug MLN4924 Elicits DNA Rereplication by Stabilizing Cdt1 in S Phase, Triggering Checkpoint Activation, Apoptosis, and Senescence in Cancer Cells.

Cancer Res. 70(24):10310-20 (2010).

[3] Soucy, T.A., et al. Targeting NEDD8-Activated Cullin-RING Ligases for the Treatment of Cancer. Clin Cancer Res 15(12): 3912-6 (2009).

[4] Milhollen, M.A., et al. MLN4924, a NEDD8-activating enzyme inhibitor, is active in diffuse large B-cell lymphoma models: rationale for treatment of NF-κB-dependent lymphoma. Blood 116(9): 1515-23 (2010).

[5] Wei, D.P., et al. Radiosensitization of Human Pancreatic Cancer Cells by MLN4924, an Investigational NEDD8-Activating Enzyme Inhibitor. Cancer Res. 72(1): 282-93 (2012).